Diabetic Peripheral Neuropathy Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
What Is the Current and Projected Market Size of the Diabetic Peripheral Neuropathy Market Through 2034?
In recent times, there has been a robust expansion in the market size of diabetic peripheral neuropathy. The market, which currently stands at $3.51 billion in 2024, is poised to escalate to $3.84 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.4%. The growth observed in the past is predominantly due to the upsurge in the elderly population, inflating incidences of diabetes, escalating healthcare costs, heightened awareness regarding diabetic complications, and the expansion of healthcare infrastructure.
Robust expansion is projected for the diabetic peripheral neuropathy market in the coming years, with projections setting its worth at $5.43 billion by 2029, growing at a compound annual growth rate (CAGR) of 9.1%. The growth anticipated in the predicted timeframe can be linked to a rise in sedentary behaviours, enhanced government initiatives and funding, an escalation in neuropathy risk factors, improved diagnostic precision, and amplified support for early detection and prevention. Significant trends within the predicted period comprise advancements in diagnostic technologies, breakthroughs in treatment technologies, greater funding in research and development, creation of less invasive procedures, and a magnified emphasis on cooperative research and development.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21170&type=smp
What Are the Core Market Drivers Propelling Growth in the Diabetic Peripheral Neuropathy Industry?
Anticipated growth in the diabetic peripheral neuropathy market is predicted to be driven by a surge in health problems related to obesity. Characterized by an excessive accumulation of body fat, obesity is a medical condition that can harm health and increase the risk of various chronic diseases. The rise in health problems due to obesity can be attributed to increased awareness, changes in lifestyle, and a growing demand for both preventive and treatment solutions, thereby leading to heightened demand for healthcare. Diabetic peripheral neuropathy aids in managing obesity by providing crucial insights into nerve damage brought about by obesity-related conditions, which helps inform targeted interventions designed to enhance patient well-being and quality of life overall. For example, the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations charged with global public health, reported in March 2024 that in 2022, 43% of adults over 18 years old were classified as overweight, and 16% were diagnosed as obese. Also, 37 million children under the age of 5 were recorded as overweight, and among those aged 5 to 19, more than 390 million were overweight, including 160 million suffering from obesity. Hence, health problems related to obesity are fueling growth in the diabetic peripheral neuropathy market.
How Is the Diabetic Peripheral Neuropathy Market Segmented?
The diabetic peripheral neuropathy market covered in this report is segmented –
1) By Disease: Type 2 Diabetic Peripheral Neuropathy, Type 1 Diabetic Peripheral Neuropathy
2) By Treatment: Pain Management Drugs, Gene Therapies
3) By Therapy: Antidepressants, Anticonvulsants
4) By Patient Population: Adult Patients, Geriatric Patients
Subsegments:
1) By Type 2 Diabetic Peripheral Neuropathy: Sensory Neuropathy, Motor Neuropathy, Autonomic Neuropathy
2) By Type 1 Diabetic Peripheral Neuropathy: Distal Symmetric Neuropathy, Mononeuropathy, Polyradiculopathy
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21170&type=smp
Which Regions Are Driving the Next Phase of the Diabetic Peripheral Neuropathy Market Growth?
North America was the largest region in the diabetic peripheral neuropathy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic peripheral neuropathy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Market Trends and Innovations Are Shaping the Future of the Diabetic Peripheral Neuropathy Industry?
A primary focus for leading companies in the diabetic peripheral neuropathy market is technological innovation, notably the development of NaV1.8 pain signal inhibitors. These provide patients with advanced, non-opioid based methods of pain management and an enhanced quality of life overall. A NaV1.8 pain signal inhibitor works by blocking the NaV1.8 sodium channel, a fundamental player in the transmission of pain signals within sensory neurons, thus ensuring relief from acute and neuropathic pain without the necessity of opioid usage. For example, Vertex Pharmaceuticals Incorporated, a biotech company based in the US, reported progress in their suzetrigine pain program in April 2024. This included the start of a Phase 3 pivotal program to address pain linked to diabetic peripheral neuropathy (DPN). Suzetrigine is a selective NaV1.8 pain signal inhibitor and has demonstrated encouraging results in early research. It was recently awarded a breakthrough therapy designation for diabetic Peripheral Neuropathy (DPN) pain management by the US-based federal agency, the Food and Drug Administration (FDA).
View the full report here:
How Is the Diabetic Peripheral Neuropathy Market Defined and What Are Its Core Parameters?
Diabetic Peripheral Neuropathy (DPN) is a nerve disorder caused by prolonged high blood sugar levels in individuals with diabetes, leading to nerve damage primarily in the legs, feet, arms, and hands. This condition occurs due to long-term high blood sugar levels, which damage the nerves and blood vessels, impairing nerve function and blood flow to the affected areas.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21170
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
